dotMD.com
Preventive Screening & Blood Biomarkers • ICD-10-CM Z12.7

Managed Care

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-11-02 • ICD-10-CM Z12.7 • 8 Linked .gov / PubMed Citations • Governance: Dr. Julian Sterling, MD, FACS (NPI #1376841536)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Managed Care Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Managed Care

3 of 3 Free Questions Remaining

What Is Managed Care?

Managed care plans are a type of health insurance . They have contracts with health care providers and medical facilities to provide care for members at reduced costs. These providers make up the plan's network. How much of your care the plan will pay for depends on the network's rules. Plans that restrict your choices usually cost you less. If you want a flexible plan, it will probably cost more. There are three types of managed care plans: Health Maintenance Organizations (HMO) usually only pay for care within the network. You choose a primary care doctor who coordinates most of your care.

Pathophysiology, Underlying Causes & Clinical Presentation

Biological expression of Managed Care (Z12.7, Preventive & Labs) reflects preventive medical correction in Managed Care (Z12.7: during the reversible). Cross-referenced with NIH MeSH (Managed Care Programs), longitudinal control is benchmarked via CBC, CMP & in Managed Care (Z12.7: eGFR Baseline).

Common Symptoms & Clinical Signs

  • • Point of Service (POS) plans let you choose between an HMO or a PPO each time you need care
  • • Presentation of Managed Care (Z12.7): age- or family-history-guided in Managed Care (Z12.7: cancer, vascular, bone,)
  • • Secondary Managed Care clinical sign: proactive annual or in Managed Care (Z12.7: semiannual health checkup)
  • • Symptom flares in Managed Care correlating with CBC, CMP & in Managed Care (Z12.7: eGFR Baseline) deviation outside Within optimal preventive reference intervals (Z12.7)

Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗

Managed Care Diagnostic Classification & Lab Markers

Metric Verified Benchmark Source
ICD-10-CM Diagnostic Code Z12.7 WHO / CMS ICD-10-CM Clinical Classification
Clinical Specialty Hub Preventive Screening & Blood Biomarkers NIH MedlinePlus Health Topics
Diagnostic / Lab Marker: CBC, CMP & in Managed Care (Z12.7: eGFR Baseline) Within optimal preventive reference intervals (Z12.7) Clinical Reference Target Range
Diagnostic / Lab Marker: 25-Hydroxy Vitamin D, in Managed Care (Z12.7: Ferritin & B12) 25(OH)D 40–65 ng/mL; Ferritin 50–150 ng/mL (Z12.7) Clinical Reference Target Range
Diagnostic / Lab Marker: ApoB, HbA1c & in Managed Care (Z12.7: hs-CRP Triad) ApoB < 80 mg/dL; HbA1c < 5.5%; hs-CRP < 1.0 mg/L (Z12.7) Clinical Reference Target Range
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance

FDA-Monographed Medications & Public Cash Price Reference for Managed Care

Check Drug Interactions →

Treatment selection for Managed Care depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Managed Care)

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
Can This Approach Help? Inside the Latest Research on Real-world benefits and safety of Ginkgo biloba extract as an add-on booster in

GKB extract as an add-on booster was effective in improving Met treatment outcomes in T2DM patients.

Drug design, development and therapy • 2018-01-15 • Randomized Controlled Trial
Multi-cohort 88/100 PMID 29670330 ↗
Can This Approach Help? Inside the Latest Research on How the body absorbs the medicine Interaction Among Amlodipine, Losartan, and

All the treatments were well tolerated overall.

Clinical pharmacology in drug development • 2026-01-15 • Randomized Controlled Trial
Multi-cohort 82/100 PMID 41549823 ↗
Can This Approach Help? Inside the Latest Research on Improved Iron Overload with Pegcetacoplan in Eculizumab-Experienced Patients with

Mean ferritin concentrations were above normal throughout the study, regardless of iron overload status.

International journal of molecular sciences • 2025-10-15 • Phase III Randomized Trial
Multi-cohort 82/100 PMID 41155315 ↗
Can This Approach Help? Inside the Latest Research on Ruxolitinib plus steroids for acute graft versus host disease: a multicenter,

Side effects (AEs) frequencies were comparable between both groups, with the exception of fewer grade 4 AEs in the RUX/steroids group (26.3% vs.

Signal transduction and targeted therapy • 2024-10-23 • Phase III Randomized Trial
Multi-cohort 82/100 PMID 39438467 ↗
Can This Approach Help? Inside the Latest Research on TRAINING-Ovary 01 (connecTed pRehabiliAtIoN pelvIc caNcer surGery): multicenter

We anticipate reporting primary endpoint results in 2024.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society • 2021-06-15 • Phase III Randomized Trial
Multi-cohort 82/100 PMID 33262113 ↗
Zero-PHI Patient Support & Cohort Discussions

Managed Care Patient Community & “People Like Me” Threads

“People Like Me” Cohort Filter (Zero-PHI)

Filter Managed Care community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Managed Care.

Related Conditions in Preventive Screening & Blood Biomarkers